Alternatively, combining CAR-T therapy with TGF-β inhibitors or other drugs may help enhance the infiltration and activity of CAR-T cells within the tumor, thereby improving treatment efficacy (137, 138). The gene discussed is TGFB1; the disease is neoplasm.